China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20

BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro diagnostic
products today announced the substantial completion of an independent internal
investigation and the expected reporting in late August 2009 of unaudited
financial results for the quarter and fiscal year ended March 31, 2009 and the
quarter ended June 30, 2009.

Independent Internal Investigation

An anonymous letter, in which allegations of irregularities and improper
conduct were made against the senior management of the Company in connection
with the Company's acquisitions of FISH and SPR, the Company's disposal of its
High Intensity Focused Ultrasound Tumor Therapy System business, its revenues
as well as its relationships with stock analysts, was received by the
Company's audit committee. The audit committee, consisting of three
independent directors, decided to initiate an independent internal
investigation into the allegations contained in the anonymous letter. In
connection with this independent internal investigation, the audit committee
engaged an independent law firm, Paul, Weiss, Rifkind, Wharton & Garrison LLP,
as well as independent forensic accountants, AlixPartners LLP, to assist the
audit committee to carry out this independent internal investigation. The
independent law firm and forensic accountants involved their experienced
personnel from their U.S. offices to conduct this independent internal
investigation and began their investigative work in April 2009 and the
investigation lasted for more than three months. The investigation covered not
only the entire senior management team but also employees from various key
departments of all operating subsidiaries of the Company. The senior
management and other relevant employees of the Company fully cooperated with
the independent law firm and forensic accountants in the course of the
investigation. During the process of the investigation, the independent law
firm reported from time to time the scope, procedures and progress of the
investigation to the audit committee. The independent law firm and forensic
accountants have substantially completed their investigative work and have
reported to the audit committee that the investigation has not identified
evidence to support the allegations made in the anonymous letter.

Mr. Xiaodong Wu, the Chairman and Chief Executive Officer of the Company
commented, "The entire senior management team is pleased that the independent
internal investigation is substantially complete and that it has found no
evidence supporting the anonymous allegations. We can now focus our efforts
back to the operations of the Company. We are thankful for the employees and
the customers who were confident in the well-being of the Company during the
past few months. We are confident that we will able to address the impact of
this independent internal investigation on the timing of our financial
reporting and other aspects of our operations and most importantly, the
Company's fundamentals remain healthy."

During the course of this independent internal investigation, the senior
management team and certain management personnel devoted significant time and
efforts to assist with the investigation, and had less time to spend on the
Company's operations. The Company believes that this has contributed to a
decline in the Company's sales in June 2009 and this decline has continued in
July. The Company's preliminary estimate of revenues for the quarter ended
June 30, 2009 is approximately Rmb210 million, subject to normal book closing
and adjustment procedures. In addition, the costs of this independent internal
investigation have increased the Company's general and administrative expenses
substantially for the quarter ended June 30, 2009 and will also increase the
general and administrative expenses for the quarter ending September 30, 2009.

Annual Audit Work

The senior management team and other selected personnel provided full
cooperation during the investigation with a view to completing the
investigation as early as possible. Due to the Company's limited staff
resources, the Company was not able to commence its work relating to the audit
of the financial statements for the Company's fiscal year ended March 31, 2009,
which was originally scheduled to begin in May 2009. As the investigation is
substantially complete, the relevant management members will start their work
relating to the annual audit. The Company expects to meet the deadline to file
the Company's annual report on Form 20-F by September 30, 2009.

Announcement of unaudited financial results for the quarter and fiscal
year ended March 31, 2009 and the quarter ended June 30, 2009

The Company expects to announce in late August 2009 the unaudited
financial results for the quarter and fiscal year ended March 31, 2009,
together with the unaudited financial results for the quarter ended June 30,
2009.

This press release contains forward-looking statements. These statements
constitute "forward-looking" statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, and as defined in the U.S. Private
Securities Litigation Reform Act of 1995. These forward-looking statements can
be identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates" and similar statements.
Such statements involve certain risks and uncertainties that could cause
actual results to differ materially from those in the forward-looking
statements. Further information regarding these and other risks is included in
the Company's filings with the U.S. Securities and Exchange Commission,
including its annual report on Form 20-F. The Company does not undertake any
obligation to update any forward-looking statement as a result of new
information, future events or otherwise, except as required under applicable
law.

(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, ... that it was acquired by Advantage Solutions. The Data Council’s IX-ONE platform ... include the industry’s leading suppliers, brokers, distributors and retailers. The Data Council will ...

(Date:8/15/2017)... -- AccuGenomics, Inc., a diagnostic company based in ... company has provided an AccuKit to the HIV Cure ... Hill and to Qura Therapeutics for evaluation in HIV ... reservoir and viral expression in human CD4+ T cells ... is a joint initiative between the University of North ...

(Date:8/10/2017)... -- Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, ... . The reputable clinic will continue to be co-owned and ... staff of four clinicians. Lipkin received his doctorate in physical ... years of experience with a strong background in manual therapy. ... 10th PRN clinic in and around the Denver ...